Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Does TH already know the drug works?

<< Previous

Bullboard Posts

Next >>

Comment by palinc2000on Oct 30, 2021 5:12pm

117 Views

Post# 34068863

RE:RE:RE:RE:Does TH already know the drug works?

That would be considered as illegal insider trading .Criminal offense!!
Nope you can argue that a lot of things at THTX are not going the way you would like but illegal insider trading is not something that would happen

quote=Bucknelly21]

Not sure what you mean, if they knew results were good you don't think they would buy shares?